Stocks and Investing Stocks and Investing
Wed, February 22, 2017
Tue, February 21, 2017
Mon, February 20, 2017
Fri, February 17, 2017
Thu, February 16, 2017

Christopher James Initiated (BCRX) at Strong Buy and Held Target at $11 on, Feb 16th, 2017


Published on 2024-10-25 20:15:57 -
  Print publication without navigation


Christopher James of Ladenburg Thalmann, Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy and Held Target at $11 on, Feb 16th, 2017.

Christopher, nor any peers, have made any analyst calls on BCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30